These findings seem to parallel the functional findings with worse visual fields in MOG (although not statistically significant) and equal or even slightly better visual acuity (also not statistically significant) in MOG-ON as compared to MS on the last examination. This evidence concerns the gene MOG and myeloid sarcoma.